Sinopharm Group Co. Ltd. (FRA:X2S)
2.110
+0.006 (0.29%)
Last updated: May 13, 2025
Sinopharm Group Revenue
Sinopharm Group had revenue of 141.66B CNY in the quarter ending March 31, 2025, a decrease of -5.97%. This brings the company's revenue in the last twelve months to 578.90B, down -3.24% year-over-year. In the year 2024, Sinopharm Group had annual revenue of 584.51B, down -2.02%.
Revenue (ttm)
578.90B CNY
Revenue Growth
-3.24%
P/S Ratio
0.09
Revenue / Employee
5.35M CNY
Employees
108,217
Market Cap
6.63B EUR
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 584.51B | -12.06B | -2.02% |
Dec 31, 2023 | 596.57B | 44.42B | 8.05% |
Dec 31, 2022 | 552.15B | 31.10B | 5.97% |
Dec 31, 2021 | 521.05B | 64.64B | 14.16% |
Dec 31, 2020 | 456.41B | 31.14B | 7.32% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 76.54B |
Deutsche Telekom AG | 118.43B |
Allianz SE | 107.35B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
Rheinmetall AG | 10.48B |
Siemens Energy AG | 37.44B |
Merck KGaA | 21.16B |